Discovery brings us one step closer to vaccine and treatment for prevalent virus. Image courtesy of the Centers for Disease Control. Scientists at The University of Texas at Austin, in collaboration ...
An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...
How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...
The oPool + display platform combines technologies to make and test large numbers of antibodies at once. Antibodies are the critical targeting agents of the immune system and the crux of immune ...
Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...
Based on these postmarketing reports, the FDA is evaluating the need for further regulatory action. The Food and Drug Administration (FDA) is investigating the risk of developing neutralizing ...
Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback